ARCHIVES

Nader Group Backs FDA In controversy Over Drug Testing

This article is from The Cancer Letter archive.

Vol. 03 No. 06 | February 11, 1977

Download PDF Visit The Full Archive

Related Articles

NCI Cooperative Group, Cancer Center Trials Listed

September 28, 2007

Increased Lung Cancer Risk After Hodgkin’s Treatment

February 22, 2002

New Jersey Commission Calls For Major Hike In Cancer Spending

September 25, 1987

New Creatinine Test Raises Questions About Accuracy Of Carboplatin Dosing

October 8, 2010

Arizona Cancer Center Seeks NCI Recognition As Comprehensive

May 29, 1987

HHS Carcinogen Guidelines For Labs Could Apply To Other

May 30, 1980